Novel Alanyl-tRNA Synthetase 2 Pathogenic Variants in Leukodystrophies

The white matter disease spectrum is associated with many genetic diseases, including AARS2, CADASIL, ALD, and others. In this study, to determine the novel alanyl-tRNA synthetase 2 mutation implicated in white matter disease, several families with an autosomal recessive inheritance pattern of white...

Full description

Bibliographic Details
Main Authors: Xingao Wang, Qun Wang, Hefei Tang, Bin Chen, Xiang Dong, Songtao Niu, Shaowu Li, Yuzhi Shi, Wei Shan, Zaiqiang Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.01321/full
_version_ 1828452514728509440
author Xingao Wang
Xingao Wang
Qun Wang
Qun Wang
Qun Wang
Qun Wang
Hefei Tang
Hefei Tang
Bin Chen
Bin Chen
Xiang Dong
Songtao Niu
Songtao Niu
Shaowu Li
Yuzhi Shi
Yuzhi Shi
Wei Shan
Wei Shan
Wei Shan
Wei Shan
Zaiqiang Zhang
Zaiqiang Zhang
author_facet Xingao Wang
Xingao Wang
Qun Wang
Qun Wang
Qun Wang
Qun Wang
Hefei Tang
Hefei Tang
Bin Chen
Bin Chen
Xiang Dong
Songtao Niu
Songtao Niu
Shaowu Li
Yuzhi Shi
Yuzhi Shi
Wei Shan
Wei Shan
Wei Shan
Wei Shan
Zaiqiang Zhang
Zaiqiang Zhang
author_sort Xingao Wang
collection DOAJ
description The white matter disease spectrum is associated with many genetic diseases, including AARS2, CADASIL, ALD, and others. In this study, to determine the novel alanyl-tRNA synthetase 2 mutation implicated in white matter disease, several families with an autosomal recessive inheritance pattern of white matter disease were analyzed by whole-exome sequencing. Variants were prioritized according to their rarity and pathogenic variants in genes already known to be associated with leukodystrophies and were confirmed by Sanger sequencing using standard protocols. We identified 5 rare variants (c.452T>C chr6:44279256 p.M151T, c.1871G>A chr6:44272054 p.W624X, c.802A>G chr6:44278128 p.M268V, c.1703-1704del chr6:-44272430-44272431 p.Q568fs, and c.179C>A chr6-44280882 p.P60H) with varying expression in 4 independent Chinese families with leukodystrophy. These single nucleotide variants (SNVs), or deletion mutations, each induced a frameshift, causing a missense mutation in alanyl-tRNA synthetase 2. These findings suggested that all mutations might contribute to the development of leukodystrophy in the examined family members. Combined with previous findings, our data confirmed that the novel mutations are located in leukodystrophy-related risk genes. We also summarized all the alanyl-tRNA synthetase 2 mutations related to the onset of leukodystrophies in adults.
first_indexed 2024-12-10T23:53:02Z
format Article
id doaj.art-59c33664712c4510834cc282c436ceea
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-10T23:53:02Z
publishDate 2019-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-59c33664712c4510834cc282c436ceea2022-12-22T01:28:40ZengFrontiers Media S.A.Frontiers in Neurology1664-22952019-12-011010.3389/fneur.2019.01321492158Novel Alanyl-tRNA Synthetase 2 Pathogenic Variants in LeukodystrophiesXingao Wang0Xingao Wang1Qun Wang2Qun Wang3Qun Wang4Qun Wang5Hefei Tang6Hefei Tang7Bin Chen8Bin Chen9Xiang Dong10Songtao Niu11Songtao Niu12Shaowu Li13Yuzhi Shi14Yuzhi Shi15Wei Shan16Wei Shan17Wei Shan18Wei Shan19Zaiqiang Zhang20Zaiqiang Zhang21Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaDepartment of Neurology, Epilepsy Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaBeijing Institute for Brain Disorders, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaDepartment of Neurology, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaBeijing Institute of Neurosurgery, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaDepartment of Neurology, Epilepsy Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaBeijing Institute for Brain Disorders, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaThe white matter disease spectrum is associated with many genetic diseases, including AARS2, CADASIL, ALD, and others. In this study, to determine the novel alanyl-tRNA synthetase 2 mutation implicated in white matter disease, several families with an autosomal recessive inheritance pattern of white matter disease were analyzed by whole-exome sequencing. Variants were prioritized according to their rarity and pathogenic variants in genes already known to be associated with leukodystrophies and were confirmed by Sanger sequencing using standard protocols. We identified 5 rare variants (c.452T>C chr6:44279256 p.M151T, c.1871G>A chr6:44272054 p.W624X, c.802A>G chr6:44278128 p.M268V, c.1703-1704del chr6:-44272430-44272431 p.Q568fs, and c.179C>A chr6-44280882 p.P60H) with varying expression in 4 independent Chinese families with leukodystrophy. These single nucleotide variants (SNVs), or deletion mutations, each induced a frameshift, causing a missense mutation in alanyl-tRNA synthetase 2. These findings suggested that all mutations might contribute to the development of leukodystrophy in the examined family members. Combined with previous findings, our data confirmed that the novel mutations are located in leukodystrophy-related risk genes. We also summarized all the alanyl-tRNA synthetase 2 mutations related to the onset of leukodystrophies in adults.https://www.frontiersin.org/article/10.3389/fneur.2019.01321/fullleukodystrophiesAARS2pathogenic variantswhite mattermutation
spellingShingle Xingao Wang
Xingao Wang
Qun Wang
Qun Wang
Qun Wang
Qun Wang
Hefei Tang
Hefei Tang
Bin Chen
Bin Chen
Xiang Dong
Songtao Niu
Songtao Niu
Shaowu Li
Yuzhi Shi
Yuzhi Shi
Wei Shan
Wei Shan
Wei Shan
Wei Shan
Zaiqiang Zhang
Zaiqiang Zhang
Novel Alanyl-tRNA Synthetase 2 Pathogenic Variants in Leukodystrophies
Frontiers in Neurology
leukodystrophies
AARS2
pathogenic variants
white matter
mutation
title Novel Alanyl-tRNA Synthetase 2 Pathogenic Variants in Leukodystrophies
title_full Novel Alanyl-tRNA Synthetase 2 Pathogenic Variants in Leukodystrophies
title_fullStr Novel Alanyl-tRNA Synthetase 2 Pathogenic Variants in Leukodystrophies
title_full_unstemmed Novel Alanyl-tRNA Synthetase 2 Pathogenic Variants in Leukodystrophies
title_short Novel Alanyl-tRNA Synthetase 2 Pathogenic Variants in Leukodystrophies
title_sort novel alanyl trna synthetase 2 pathogenic variants in leukodystrophies
topic leukodystrophies
AARS2
pathogenic variants
white matter
mutation
url https://www.frontiersin.org/article/10.3389/fneur.2019.01321/full
work_keys_str_mv AT xingaowang novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT xingaowang novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT qunwang novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT qunwang novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT qunwang novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT qunwang novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT hefeitang novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT hefeitang novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT binchen novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT binchen novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT xiangdong novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT songtaoniu novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT songtaoniu novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT shaowuli novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT yuzhishi novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT yuzhishi novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT weishan novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT weishan novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT weishan novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT weishan novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT zaiqiangzhang novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies
AT zaiqiangzhang novelalanyltrnasynthetase2pathogenicvariantsinleukodystrophies